Investigation on environmental factors contributing to bispecific antibody stability and the reversal of self-associated aggregates
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Investigation on environmental factors contributing to bispecific antibody stability and the reversal of self-associated aggregates ; volume:11 ; number:1 ; day:23 ; month:8 ; year:2024 ; pages:1-18 ; date:12.2024
Bioresources and Bioprocessing ; 11, Heft 1 (23.8.2024), 1-18, 12.2024
- Creator
-
Ingavat, Nattha
Dzulkiflie, Nuruljannah
Liew, Jia Min
Wang, Xinhui
Leong, Eunice
Loh, Han Ping
Ng, Say Kong
Yang, Yuansheng
Zhang, Wei
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40643-024-00796-y
- URN
-
urn:nbn:de:101:1-2411120857080.949604085133
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ingavat, Nattha
- Dzulkiflie, Nuruljannah
- Liew, Jia Min
- Wang, Xinhui
- Leong, Eunice
- Loh, Han Ping
- Ng, Say Kong
- Yang, Yuansheng
- Zhang, Wei
- SpringerLink (Online service)
Other Objects (12)
A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer’s Disease Mice
Improvement of pharmacokinetics of small recombinant bispecific antibody molecules
A human bispecific antibody neutralizes botulinum neurotoxin serotype A
Bispecific antibody-activated T cells enhance NK cell-mediated antibody-dependent cellular cytotoxicity
Ipilimumab augments antitumor activity of bispecific antibody-armed T cells
Non-affinity platform for processing knob-into-hole bispecific antibody
Cell-type specific potent Wnt signaling blockade by bispecific antibody
Infectious complications of bispecific antibody therapy in patients with multiple myeloma
Bispecific antibody (ABL602 2 + 1) induced bistable acute myeloid leukemia kinetics
Polyclonal tumor-specific activation of cytotoxic effector cells by bispecific antibody constructs
T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors
Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies
A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer’s Disease Mice
Improvement of pharmacokinetics of small recombinant bispecific antibody molecules
A human bispecific antibody neutralizes botulinum neurotoxin serotype A
Bispecific antibody-activated T cells enhance NK cell-mediated antibody-dependent cellular cytotoxicity
Ipilimumab augments antitumor activity of bispecific antibody-armed T cells
Non-affinity platform for processing knob-into-hole bispecific antibody
Cell-type specific potent Wnt signaling blockade by bispecific antibody
Infectious complications of bispecific antibody therapy in patients with multiple myeloma
Bispecific antibody (ABL602 2 + 1) induced bistable acute myeloid leukemia kinetics
Polyclonal tumor-specific activation of cytotoxic effector cells by bispecific antibody constructs
T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors
Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies
A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer’s Disease Mice
Improvement of pharmacokinetics of small recombinant bispecific antibody molecules
A human bispecific antibody neutralizes botulinum neurotoxin serotype A
Bispecific antibody-activated T cells enhance NK cell-mediated antibody-dependent cellular cytotoxicity
Ipilimumab augments antitumor activity of bispecific antibody-armed T cells
Non-affinity platform for processing knob-into-hole bispecific antibody
Cell-type specific potent Wnt signaling blockade by bispecific antibody
Infectious complications of bispecific antibody therapy in patients with multiple myeloma
Bispecific antibody (ABL602 2 + 1) induced bistable acute myeloid leukemia kinetics
Polyclonal tumor-specific activation of cytotoxic effector cells by bispecific antibody constructs
T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors